News

Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth?
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
NBC New York23d
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
It is unclear whether orforglipron will have a hefty list price ... and obesity products. While injections will likely remain a popular option, a once-daily pill like Eli Lilly's could be much ...
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.
Nasdaq2d
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's latest product announcement.